From: The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life
The whole sample (n = 275) | |
---|---|
age (y) | 70.9 ± 8.4 |
BMI | 26.8 ± 4.6 |
smoking habit | |
active | 65 (23.6 %) |
ex | 184 (66.9 %) |
never smoker | 26 (9.5 %) |
FEV1 (I) | 1.5 ± .05 |
FEV1 % pred, | 55.9 ± 18.8 |
FEV1/FVC (%) | 55.9 ± 10.3 |
FEV1/VC | 51.1 ± 10.6 |
RV % pred. | 156.9 ± 46.2 |
TLCO/VA % pred | 70.9 ± 26.2 |
FEV1 reversibility | 6.7 ± 7.9 |
6’ walking test (mt) | 233.3 ± 92.7 |
MRC score | 2.3 ± 1.2 |
BODE index | 4.4 ± 2.6 |
Charlson comorb. index | 3.3 ± 1.8 |